Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (5348)	1/16/1998 2:19:00 PM
From: Edward Paule	Read Replies (2) \| Respond to of 17367

The other day, a local network TV station in Philadelphia had a short segment about a meningococcemia death on the 11 o'clock news. The video showed the outside of a hospital with a graphic that read, "MENENGITIS // Huntington, NJ". In the audio, a reporter said, "a child has died here from a rare blood disease known as meningococcemia." The clip then showed the grief stricken family that was shocked at the suddenness of the event. This leads me to ask the question, do we know the names of which hospitals are participating in the phase III trial? If this hospital was one of them, then I certainly hope this kid was in the placebo group. Also, if the fact that a child has died from meningococcemia is in the public domain, and the names of the hospitals doing the trials is in the public domain, then with some leg work, one could determine the number of deaths in the trial. So why is this information only privy to the company? - Ed.

To: aknahow who wrote (5348)	1/16/1998 2:32:00 PM
From: Tharos	Respond to of 17367

George, We had a holiday here, and I got the chance to play a round of charity golf (in the rain). Had another American in the group that is a pharmicist and talk eventually turned to investments. He said his investment group looked at Xoma and asked the question, "Would anyone here be willing to purchase $25K of this stock?" Further query revealed most in his group did not have $25K, consequently I took the que of no portfolio-modeling theory being used by the group as an indication they were novices and let the issue die.